Mutation analysis of the AATF gene in breast cancer families

Maria Haanpää1, Mervi Reiman, Jenni Nikkilä

  • 1Laboratory of Cancer Genetics, Oulu University Hospital, P,O, Box 22, FIN-90221 Oulu, Finland. maappi@mail.student.oulu.fi

BMC Cancer
|December 23, 2009
PubMed
Abstract

Insights

This study investigated the AATF gene in Finnish families with a history of breast cancer. No disease-causing mutations were found, suggesting AATF is not a significant factor in inherited breast cancer risk.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Inherited predisposition accounts for 5-10% of breast cancer cases.
  • Susceptibility factors often maintain genomic integrity.
  • The AATF gene regulates transcription, cell proliferation, and apoptosis, interacting with known breast cancer risk factors like p53 and ATM/ATR/CHEK2.

Purpose of the Study:

  • To screen the AATF gene for germline mutations in Finnish familial breast cancer cases.
  • To evaluate the potential role of AATF in heritable breast cancer susceptibility.

Main Methods:

  • Screened the entire coding region of the AATF gene.
  • Utilized conformation sensitive gel electrophoresis and direct sequencing.
  • Analyzed 121 affected index cases from Finnish cancer families.

Main Results:

  • Identified seven sequence variations: one missense and six intronic.
  • In silico analyses and case-control comparisons indicated no pathogenic variants.
  • No significant association between AATF mutations and familial breast cancer was observed.

Conclusions:

  • This is the first study to screen the AATF gene for mutations in familial breast cancer.
  • The findings do not support AATF as a major susceptibility gene for breast cancer in the studied Finnish population.